Daniel Solorio

Daniel Solorio is a regulatory affairs and drug development executive with over 25 years of experience across the pharmaceutical R&D landscape. They have managed high-performance teams and led various regulatory activities, including clinical development programs and FDA submissions. Currently, Daniel serves as the S.V.P. of Regulatory Program Management at ProPharma Group, where they lead the US Regulatory Program Management team and provide strategic input for clients in the pharma, device, and biotech sectors. Daniel's previous roles include Project Manager and Sr. Project Manager at Premier Research Group, as well as positions in various organizations such as Iroko Pharmaceuticals and Cetero Research. They earned their education from the University of Utah and The George Washington University School of Medicine and Health Sciences.